Prostate cancer surgery or radical treatments are typically not recommended for older men whose overall life expectancy is estimated to be less than 10 years, or for patients with severe, life-limiting comorbidities where the risks of invasive surgery outweigh potential oncological benefits. Medical guidelines emphasize that biological fitness, general health status, and cancer aggressiveness matter far more than chronological age alone when determining appropriate clinical pathways.